How do periodontal infections affect the onset and progression of Alzheimer's disease?

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 3, 2014, Pages 460-466

  Shaik, Munvar M ^a   Ahmad, Sultan ^b   Gan, Siew H ^a   Abuzenadah, Adel M ^b   Ahmad, Ejaz ^b   Tabrez, Shams ^b   Ahmed, Farid ^b   Kamal, Mohammad A ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Alzheimer's disease; Dementia; Inflammation; Periodontal disease

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DISEASE COURSE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIODONTAL DISEASE; PROTEIN EXPRESSION; RISK FACTOR; TISSUE INJURY; TREPONEMA DENTICOLA; COMPLICATION; DIABETES MELLITUS, TYPE 2; INFECTION; ONSET AGE;

AGE OF ONSET; ALZHEIMER DISEASE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; INFECTION; PERIODONTAL DISEASES;

EID: 84904470329     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113126660152     Document Type: Article

References (82)

1. Richards SS, Hendrie HC. Diagnosis, management, and treatment of Alzheimer disease: a guide for the internist. Arch Int Med 1999; 159: 789-98.
2. Dementia cases set to triple by 2050 but still largely ignored; Available from http://www.who.int/mediacentre/news/releases/2012/dementia_20120411/en/ [Accessed on 16-06-2012).
3. World Health Organisation - Dementia; Available from http://www.who.int/mediacentre/factsheets/fs362/en/index.html [Accessed on 16-06-2012].
4. Eke P, Barker L. Prevalence of Periodontal Disease in the United States: NHANES 1999-2004. International Association of Dental Research; 2007.
5. Shiau HJ, Reynolds MA. Sex differences in destructive periodontal disease: exploring the biologic basis. J Periodontol 2010: 81(11): 1505-17.
6. Rajhans NS, Kohad RM, Chaudhari VG, Mhaske NH. A clinical study of the relationship between diabetes mellitus and periodontal disease. J Indian Soc Periodontol 2011; 15(4): 388-92.
7. Sparks Stein P, Steffen MJ, Smith C, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement 2012; 8(3): 196-203.
8. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007; 4(2): 147-52.
9. Risner ME, Saunders AM, Altman JF, et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenom J 2006; 6(4): 246-54.
10. Southerland JH, Taylor GW, Offenbacher S. Diabetes and periodontal infection: making the connection. Clin Diabetes 2005; 23(4): 171-8.
11. Haffajee AD, Socransky SS. Introduction to microbial aspects of periodontal biofilm communities, development and treatment. Periodontology 2006; 42: 7-12.
12. Tatakis DN, Kumar PS. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am 2005; 49(3): 491-516.
13. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003; 74(3): 391-401.
14. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann NY Acad Sci 2007; 1098: 230-51.
15. Mark LL, Haffajee AD, Socransky SS, et al. Effect of the interleukin-1 genotype on monocyte IL-1beta expression in subjects with adult periodontitis. J Periodontal Res 2000; 35(3): 172-7.
16. Manolagas SC. Estrogen loss, cytokines, macrophages, lymphocytes, osteoclasts and bone loss: Six characters in search of an author or an endocrine-immune system relay causing osteoporosis? BoneKEy-Osteovision 2002; 2002: 1138.
17. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005; 76(11 Suppl): 2033-41.
18. Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin Exp Immunol 2009; 156(3): 479-87.
19. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366(9499): 1809-20.
20. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2(8): 675-80.
21. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388(4): 621-5.
22. Sun Y, Shu R, Li CL, Zhang MZ Gram-negative periodontal bacteria induce the activation of Toll-like receptors 2 and 4, and cytokine production in human periodontal ligament cells. J Periodontol 2010; 81(10): 1488-96.
23. O'Neill LA. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 2003; 3(4): 396-403.
24. Carmody RJ, Chen YH. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 2007; 4(1): 31-41.
25. Wang P, Meinhardt B, Andre R, et al. The interleukin-1-related cytokine IL-1F8 is expressed in glial cells, but fails to induce IL-1beta signalling responses. Cytokine 2005; 29(6): 245-50.
26. Passoja A, Puijola I, Knuuttila M, et al. Serum levels of interleukin-10 and tumour necrosis factor-alpha in chronic periodontitis. J Clin Periodontol 2010; 37(10): 881-7.
27. Sakai A, Ohshima M, Sugano N, Otsuka K, Ito K. Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. J Periodontol 2006; 77(5): 856-64.
28. Chen K, Huang J, Gong W, et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007; 7(10): 1271-85.
29. Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205(13): 3007-18.
30. Sun Y, Guo QM, Liu DL, Zhang MZ, Shu R. In vivo expression of Toll-like receptor 2, Toll-like receptor 4, CSF2 and LY64 in Chinese chronic periodontitis patients. Oral Dis 2010; 16(4): 343-50.
31. Lappin DF, Sherrabeh S, Erridge C. Stimulants of Toll-like receptors 2 and 4 are elevated in saliva of periodontitis patients compared with healthy subjects. J Clin Periodontol 2011; 38(4): 318-25.
32. Wang PL, Azuma Y, Shinohara M, Ohura K. Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Biochem Biophys Res Commun 2000; 273(3): 1161-7.
33. Tabeta K, Yamazaki K, Akashi S, et al. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun 2000; 68(6): 3731-5.
34. Gutierrez-Venegas G, Cruz-Arrieta S, Villeda-Navarro M, Mendez-Mejia JA. Histamine promotes the expression of receptors TLR2 and TLR4 and amplifies sensitivity to lipopolysaccharide and lipoteichoic acid treatment in human gingival fibroblasts. Cell Biol Int 2011; 35(10): 1009-17.
35. Mori Y, Yoshimura A, Ukai T, et al. Immunohistochemical localization of Toll-like receptors 2 and 4 in gingival tissue from patients with periodontitis. Oral Microbiol Immunol 2003; 18(1): 54-8.
36. Wittebole X, Coyle SM, Kumar A, et al. Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating. Clin Exp Immunol 2005; 141(1): 99-106.
37. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. Human tolllike receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 1998; 188(11): 2091-7.
38. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-76.
39. Akira S, Sato S. Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 2003; 35(9): 555-62.
40. Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 2007; 56(2): 384-402.
41. Park CR. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001; 25(4): 311-23.
42. Watson GS, Peskind ER, Asthana S, et al. Insulin increases CSF Abeta42 levels in normal older adults. Neurology 2003; 60(12): 1899-903.
43. Small SA, Perera GM, DeLaPaz R, Mayeux R, Stern Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 1999; 45(4): 466-72.
44. Frolich L, Blum-Degen D, Bernstein HG, et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 1998; 105(4-5): 423-38.
45. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the betaamyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003; 100(7): 4162-7.
46. Zhao L, Teter B, Morihara T, et al. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. J Neurosci 2004; 24(49): 11120-6.
47. Watson GS, Cholerton BA, Reger MA, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005; 13(11): 950-8.
48. Reger MA, Watson GS, Frey WH, et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 2006; 27(3): 451-8.
49. Negrean M, Stirban A, Stratmann B, et al. Effects of low-and high-advanced glycation endproduct meals on macro-and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 2007; 85(5): 1236-43.
50. Sullivan KA, Feldman EL. New developments in diabetic neuropathy. Curr Opin Neurol 2005; 18(5): 586-90.
51. Lue LF, Walker DG, Brachova L, et al. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol 2001; 171(1): 29-45.
52. Deane R, Yan DS, Submamaryan RK, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003; 9(7): 907-13.
53. D'Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83(2): 156-60.
54. Miklossy J. Alzheimer's disease--a spirochetosis? Neuroreport 1993; 4(9): 1069.
55. Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 2002; 17(2): 113-8.
56. Kamer AR, Craig RG, Dasanayake AP, et al. Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement 2008; 4(4): 242-50.
57. Gatz M, Mortimer JA, Fratiglioni L, et al. Potentially modifiable risk factors for dementia in identical twins. Alzheimers Dement 2006; 2(2): 110-7.
58. Stein PS, Desrosiers M, Donegan SJ, Yepes JF, Kryscio RJ. Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc 2007; 138(10): 1314-22.
59. Al-Shammari KF, Al-Khabbaz AK, Al-Ansari JM, Neiva R, Wang HL. Risk indicators for tooth loss due to periodontal disease. J Periodontol 2005; 76(11): 1910-8.
60. Jovino-Silveira RC, Caldas Ade F, de Souza EH, Gusmao ES. Primary reason for tooth extraction in a Brazilian adult population. Oral Health Prev Dent 2005; 3(3): 151-7.
61. Noble JM, Borrell LN, Papapanou PN, et al. Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J Neurol Neurosurg Psychiatry 2009; 80(11): 1206-11.
62. Stewart R, Sabbah W, Tsakos G, D'Aiuto F, Watt RG. Oral health and cognitive function in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom Med 2008; 70(8): 936-41.
63. Holmes C, El-Okl M, Williams AL, et al. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003; 74(6): 788-9.
64. Lerner AJ, Hedera P, Koss E, Stuckey J, Friedland RP. Delirium in Alzheimer disease. Alzheimer Dis Assoc Disord 1997; 11(1): 16-20.
65. Schmidt R, Schmidt H, Curb JD, et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002; 52(2): 168-74.
66. Balin BJ, Little CS, Hammond CJ, et al. Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis 2008; 13(4): 371-80.
67. Itzhaki RF, Wozniak MA. Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis 2008; 13(4): 393-405.
68. Miklossy J. Chronic inflammation and amyloidogenesis in Alzheimer's disease-role of Spirochetes. J Alzheimers Dis 2008; 13(4): 381-91.
69. Urosevic N, Martins RN. Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J Alzheimers Dis 2008; 13(4): 421-35.
70. Zijlstra EE, Swart GR, Godfroy FJ, Degener JE. Pericarditis, pneumonia and brain abscess due to a combined Actinomyces--Actinobacillus actinomycetemcomitans infection. J Infect 1992; 25(1): 83-7.
71. Miklossy J, Kasas S, Janzer RC, Ardizzoni F, Van der Loos H. Further ultrastructural evidence that spirochaetes may play a role in the aetiology of Alzheimer's disease. Neuroreport 1994; 5(10): 1201-4.
72. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25(2): 134-44.
73. Beck JD, Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005; 76(11 Suppl): 2089-100.
74. Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Atherosclerosis Risk In Communities study. Blood Purif 2007; 25(1): 125-32.
75. Pussinen PJ, Paju S, Mantyla P, Sorsa T. Serum microbial-and host-derived markers of periodontal diseases: a review. Curr Med Chem 2007; 14(22): 2402-12.
76. Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol 2007; 78(12): 2289-302.
77. Ship JA. Oral health of patients with Alzheimer's disease. J Am Dent Assoc 1992; 123(1): 53-8.
78. Van Dyke TE, Kornman KS. Inflammation and factors that may regulate inflammatory response. J Periodontol 2008; 79(8 Suppl): 1503-7.
79. Kamer AR, Craig RG, Pirraglia E, et al. TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J Neuroimmunol 2009; 216(1-2): 92-7.
80. Papapanou PN, Neiderud AM, Disick E, et al. Longitudinal stability of serum immunoglobulin G responses to periodontal bacteria. J Clin Periodontol 2004; 31(11): 985-90.
81. McArthur WP. Effect of aging on immunocompetent and inflammatory cells. Periodontology 2000; 16: 53-79.
82. Papapanou PN, Neiderud AM, Papadimitriou A, Sandros J, Dahlen G. Checkerboard assessments of periodontal microbiota and serum antibody responses: a case-control study. J Periodontol 2000; 71(6): 885-97.